Janux Therapeutics Selling Its TRACTr Technology in $1 Billion Deal
The goal of the collaboration is to use Janux’ proprietary TRACTr technology to engineer novel.
TRACTr
The goal of the collaboration is to use Janux’ proprietary TRACTr technology to engineer novel.